Boston launches thrombus remover in Europe:
This article was originally published in Clinica
Executive Summary
Boston Scientific's Scimed division has begun European distribution of its Rescue Thrombus Management System for removal of fresh thrombus in coronary arteries during acute myocardial infarction. The console and disposable catheter is used when there is angiographic, angioscopic, or ultrasound evidence of fresh thrombus using suction. It can be used as sole therapy, or with adjunctive balloon angioplasty or stenting. It is also indicated for saphenous vein grafts.
You may also be interested in...
Japan Grants Global-First Approval To Zolbetuximab, 15 Other New Drugs
Astellas's first-in class CLDN18.2-targeting antibody receives its first approval worldwide, while crovalimab and a number of drugs for rare diseases also receive nods from regulators and are now awaiting reimbursement price-listing.
Hanmi-OCI Merger Hits Wall As Brothers Win Shareholder Vote, Board Seats
The planned merger of Korea's Hanmi Pharm Group with OCI Group hits a major speed bump as the two sons of Hanmi's founder and other candidates recommended by them secture board seats. But it remains to be seen how the Lim brothers will fulfil their ambitious promises.
Beauty Firms Using AI-Based Tools Could Be Subject To Health Privacy Laws In US States
Using AI-based programs to collect and store consumer information risks running afoul of new health privacy laws cropping up in US states. Lack of federal regulation or guidance on the issue is one of the biggest challenges for beauty firms deploying AI, according to Stacy Marcus, partner at Reed Smith LLP.